Contrasting gray and white matter changes in preclinical Huntington disease:. An MRI study Neurolog

Contrasting gray and white matter changes in preclinical Huntington disease:. An MRI study Neurology 2010 74:. 1208-1216 17 weeks pregnant In Not onset of Huntington's disease, in the consideration by the VBM and the FA at the MRI, the gray matter of especially the basal ganglia and the thalamus cortical pathway the volume is reduced, a decrease in FA values of a wide range of white matter is observed, onset can be analogized 17 weeks pregnant by the degree of change
. Normal and mutant HTT interact to affect 17 weeks pregnant clinical severity and progression in Huntington disease Neurology 2009 73:. 1280-1285 and symptoms that there are many normal repeat number if the extension of the pathological CAG repeat number of HTT gene is about 40 in Huntington's disease becomes stronger, the extension of the pathological CAG repeat number is made lightly Symptoms and if 50 degree and strong there are many normal repeat number
Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study:.. Cross-sectional analysis of baseline data Lancet Neurol 2009 Jul 29. [Epub ahead of print] and brain form in MRI in Huntington's disease patients before motor symptoms onset such as the failure of the changes and neuropsychological functions are observed.
A longitudinal 17 weeks pregnant diffusion tensor imaging study in symptomatic Huntington's disease. JNNP. 2009 Feb 22. in the evaluation of in [Epub ahead of print] 17 weeks pregnant of Huntington's disease patients diffusion tensor image, seen a decrease in diffusion properties in the caudate nucleus and the putamen MMSE Although reverse correlation with the score was seen was seen changes over time in one year.
. Randomized Controlled Trial of Ethyl-Eicosapentaenoic Acid in Huntington Disease: The TREND-HD Study Arch Neurol 2008; 65 (12):.. 1582-1589 ω3 fatty acid (Ethyl Eicosapentaenoic Acid) for the six months 2g internal use of Huntington's Disease and not to improve motor function
... Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease JNNP 2008; 79: 948-51 Epub 2008 Mar 20. 1 cases out of two cases who received a transplant of fetal striatum in Huntington's disease The increase in D2 receptor is observed in an improvement in symptoms over 5 years PET, would be an effective therapeutic means.
Comment